Business
Bausch Health's Aesthetic Business, Solta Medical, Surpasses Milestone of 5 Million Skin Tightening Treatments with Thermage(R) Non-Surgical System
LAVAL, QC / ACCESS Newswire / September 5, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:...
About this update from Bausch Health Companies Inc.
[{"type":"text","content":"Bausch Health's Aesthetic Business, Solta Medical, Surpasses Milestone of 5 Million Skin Tightening Treatments with Thermage(R) Non-Surgical SystemLAVAL, QC / ACCESS Newswire / September 5, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, and Solta Medical, a global leader in the medical aesthetics market, today announced that the Company's proven Thermage technology has successfully been used to perform more than 5 million skin tightening and smoothing treatments.Thermage utilizes monopolar radiofrequency energy that can safely heat layers of skin and stimulate collagen production, naturally. With every Thermage treatment, patients embrace a non-invasive path to visibly smoother, tighter skin-rooted in proven technology, backed by patented innovation, and trusted around the globe. Patients rely on Thermage for their yearly facial, body, and eye treatments. It is the only non-invasive technology indicated for use on the upper and lower eyelids for wrinkles.\"Thermage has surpassed 5 million tips used worldwide, a testament to the trusted science behind every treatment,\" said Jiny Kim, Senior Vice President, Solta Medical, Bausch Health. \"We want to thank every patient, consumer, healthcare provider, and employee for being part of a global story that keeps growing. Thermage is dedicated to helping individuals enhance their natural beauty through non-invasive skin tightening solutions. We will continue to advance our technology by investing in research and development, as well as gathering clinical evidence. We are just only getting started.\"\"We are proud to celebrate this incredible milestone achieved by Thermage technology,\" said Thomas J. Appio, Chief Executive Office, Bausch Health. \"This accomplishment reflects our commitment to innovative solutions in aesthetics and demonstrates the trust that patients and providers place in our products globally.\"About Thermage® FLX systemINDICATIONSThe radiofrequency energy only delivery components of the Thermage® FLX system and accessories are indicated for use in:Dermatologic and general surgical procedures for electrocoagulation and hemostasisNon-invasive treatment of wrinkles around the eyes, including upper and lower eyelidsNon-invasive treatment of wrinklesThe simultaneous application of radiofrequency energy and...